nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.131	0.5	CrCrCtD
Propranolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.131	0.5	CrCrCtD
Propranolol—ADRB2—chronic obstructive pulmonary disease	0.116	0.373	CbGaD
Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.0998	0.32	CbGaD
Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.0962	0.308	CbGaD
Propranolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0463	0.141	CbGbCtD
Propranolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0456	0.139	CbGbCtD
Propranolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0351	0.107	CbGbCtD
Propranolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0351	0.107	CbGbCtD
Propranolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0346	0.105	CbGbCtD
Propranolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0346	0.105	CbGbCtD
Propranolol—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0116	0.0353	CbGbCtD
Propranolol—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0116	0.0353	CbGbCtD
Propranolol—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00909	0.0277	CbGbCtD
Propranolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00881	0.0268	CbGbCtD
Propranolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00881	0.0268	CbGbCtD
Propranolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00785	0.0239	CbGbCtD
Propranolol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00739	0.0225	CbGbCtD
Propranolol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00499	0.0152	CbGbCtD
Propranolol—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00486	0.0148	CbGbCtD
Propranolol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00476	0.0145	CbGbCtD
Propranolol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00424	0.0129	CbGbCtD
Propranolol—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00416	0.0127	CbGbCtD
Propranolol—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00393	0.012	CbGbCtD
Propranolol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00249	0.00758	CbGbCtD
Propranolol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00235	0.00716	CbGbCtD
Propranolol—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000256	0.00406	CcSEcCtD
Propranolol—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.00405	CcSEcCtD
Propranolol—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00399	CcSEcCtD
Propranolol—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.00394	CcSEcCtD
Propranolol—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00393	CcSEcCtD
Propranolol—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000245	0.00388	CcSEcCtD
Propranolol—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00385	CcSEcCtD
Propranolol—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00379	CcSEcCtD
Propranolol—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000238	0.00377	CcSEcCtD
Propranolol—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000237	0.00375	CcSEcCtD
Propranolol—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000233	0.0037	CcSEcCtD
Propranolol—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000233	0.0037	CcSEcCtD
Propranolol—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00368	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00367	CcSEcCtD
Propranolol—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00356	CcSEcCtD
Propranolol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000221	0.0035	CcSEcCtD
Propranolol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000215	0.0034	CcSEcCtD
Propranolol—Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.000214	0.064	CrCbGaD
Propranolol—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00336	CcSEcCtD
Propranolol—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00336	CcSEcCtD
Propranolol—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00336	CcSEcCtD
Propranolol—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000208	0.0033	CcSEcCtD
Propranolol—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000208	0.0033	CcSEcCtD
Propranolol—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00327	CcSEcCtD
Propranolol—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00327	CcSEcCtD
Propranolol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000205	0.00325	CcSEcCtD
Propranolol—Metipranolol—ADRB2—chronic obstructive pulmonary disease	0.000204	0.061	CrCbGaD
Propranolol—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00319	CcSEcCtD
Propranolol—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00318	CcSEcCtD
Propranolol—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00316	CcSEcCtD
Propranolol—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00315	CcSEcCtD
Propranolol—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00315	CcSEcCtD
Propranolol—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00314	CcSEcCtD
Propranolol—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00314	CcSEcCtD
Propranolol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000198	0.00314	CcSEcCtD
Propranolol—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.0031	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00309	CcSEcCtD
Propranolol—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00308	CcSEcCtD
Propranolol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00019	0.00302	CcSEcCtD
Propranolol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000189	0.00299	CcSEcCtD
Propranolol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000189	0.00299	CcSEcCtD
Propranolol—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00297	CcSEcCtD
Propranolol—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00297	CcSEcCtD
Propranolol—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00297	CcSEcCtD
Propranolol—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00296	CcSEcCtD
Propranolol—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00293	CcSEcCtD
Propranolol—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00293	CcSEcCtD
Propranolol—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00291	CcSEcCtD
Propranolol—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.0029	CcSEcCtD
Propranolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000182	0.0544	CrCbGaD
Propranolol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00286	CcSEcCtD
Propranolol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000178	0.00282	CcSEcCtD
Propranolol—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.0028	CcSEcCtD
Propranolol—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.0028	CcSEcCtD
Propranolol—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00279	CcSEcCtD
Propranolol—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00275	CcSEcCtD
Propranolol—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00274	CcSEcCtD
Propranolol—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00271	CcSEcCtD
Propranolol—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00271	CcSEcCtD
Propranolol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00017	0.0027	CcSEcCtD
Propranolol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00268	CcSEcCtD
Propranolol—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00266	CcSEcCtD
Propranolol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00263	CcSEcCtD
Propranolol—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00261	CcSEcCtD
Propranolol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00259	CcSEcCtD
Propranolol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000163	0.00258	CcSEcCtD
Propranolol—Cough—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00257	CcSEcCtD
Propranolol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00257	CcSEcCtD
Propranolol—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000162	0.0485	CrCbGaD
Propranolol—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00256	CcSEcCtD
Propranolol—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00255	CcSEcCtD
Propranolol—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.00016	0.0479	CrCbGaD
Propranolol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00252	CcSEcCtD
Propranolol—Cough—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00252	CcSEcCtD
Propranolol—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00251	CcSEcCtD
Propranolol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00251	CcSEcCtD
Propranolol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000158	0.0025	CcSEcCtD
Propranolol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.0025	CcSEcCtD
Propranolol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.0025	CcSEcCtD
Propranolol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.0025	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00249	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00249	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00244	CcSEcCtD
Propranolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00244	CcSEcCtD
Propranolol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00243	CcSEcCtD
Propranolol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00241	CcSEcCtD
Propranolol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00241	CcSEcCtD
Propranolol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00239	CcSEcCtD
Propranolol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00239	CcSEcCtD
Propranolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00237	CcSEcCtD
Propranolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00236	CcSEcCtD
Propranolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00236	CcSEcCtD
Propranolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00236	CcSEcCtD
Propranolol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00236	CcSEcCtD
Propranolol—Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.000148	0.0444	CrCbGaD
Propranolol—Infection—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00234	CcSEcCtD
Propranolol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00234	CcSEcCtD
Propranolol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00234	CcSEcCtD
Propranolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00233	CcSEcCtD
Propranolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00231	CcSEcCtD
Propranolol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00229	CcSEcCtD
Propranolol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00227	CcSEcCtD
Propranolol—Betaxolol—ADRB2—chronic obstructive pulmonary disease	0.000143	0.0427	CrCbGaD
Propranolol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00226	CcSEcCtD
Propranolol—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.000142	0.0423	CrCbGaD
Propranolol—Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.000142	0.0423	CrCbGaD
Propranolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00223	CcSEcCtD
Propranolol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00221	CcSEcCtD
Propranolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.0022	CcSEcCtD
Propranolol—Bisoprolol—ADRB2—chronic obstructive pulmonary disease	0.000138	0.0412	CrCbGaD
Propranolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00218	CcSEcCtD
Propranolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00218	CcSEcCtD
Propranolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.00216	CcSEcCtD
Propranolol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00216	CcSEcCtD
Propranolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00215	CcSEcCtD
Propranolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00215	CcSEcCtD
Propranolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00214	CcSEcCtD
Propranolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00214	CcSEcCtD
Propranolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00213	CcSEcCtD
Propranolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00213	CcSEcCtD
Propranolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00212	CcSEcCtD
Propranolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00212	CcSEcCtD
Propranolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00212	CcSEcCtD
Propranolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000132	0.0021	CcSEcCtD
Propranolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.00209	CcSEcCtD
Propranolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00208	CcSEcCtD
Propranolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00208	CcSEcCtD
Propranolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00208	CcSEcCtD
Propranolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00208	CcSEcCtD
Propranolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00208	CcSEcCtD
Propranolol—Acebutolol—ADRB2—chronic obstructive pulmonary disease	0.000131	0.039	CrCbGaD
Propranolol—Carvedilol—VEGFA—chronic obstructive pulmonary disease	0.00013	0.0389	CrCbGaD
Propranolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00206	CcSEcCtD
Propranolol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00206	CcSEcCtD
Propranolol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00206	CcSEcCtD
Propranolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00206	CcSEcCtD
Propranolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00206	CcSEcCtD
Propranolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.00013	0.0388	CrCbGaD
Propranolol—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00205	CcSEcCtD
Propranolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00204	CcSEcCtD
Propranolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000128	0.00204	CcSEcCtD
Propranolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000128	0.00203	CcSEcCtD
Propranolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00203	CcSEcCtD
Propranolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00202	CcSEcCtD
Propranolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00202	CcSEcCtD
Propranolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00201	CcSEcCtD
Propranolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.002	CcSEcCtD
Propranolol—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000126	0.002	CcSEcCtD
Propranolol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.002	CcSEcCtD
Propranolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.00199	CcSEcCtD
Propranolol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00198	CcSEcCtD
Propranolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.00197	CcSEcCtD
Propranolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00197	CcSEcCtD
Propranolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00197	CcSEcCtD
Propranolol—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00197	CcSEcCtD
Propranolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00196	CcSEcCtD
Propranolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00196	CcSEcCtD
Propranolol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00194	CcSEcCtD
Propranolol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00194	CcSEcCtD
Propranolol—Terbinafine—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0367	CrCbGaD
Propranolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00193	CcSEcCtD
Propranolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00191	CcSEcCtD
Propranolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00191	CcSEcCtD
Propranolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.0019	CcSEcCtD
Propranolol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00188	CcSEcCtD
Propranolol—Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.000119	0.0355	CrCbGaD
Propranolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00188	CcSEcCtD
Propranolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00188	CcSEcCtD
Propranolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00187	CcSEcCtD
Propranolol—Betaxolol—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0353	CrCbGaD
Propranolol—Cinacalcet—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0353	CrCbGaD
Propranolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00187	CcSEcCtD
Propranolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00186	CcSEcCtD
Propranolol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00186	CcSEcCtD
Propranolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00186	CcSEcCtD
Propranolol—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00184	CcSEcCtD
Propranolol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00183	CcSEcCtD
Propranolol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00183	CcSEcCtD
Propranolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00181	CcSEcCtD
Propranolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.0018	CcSEcCtD
Propranolol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.0018	CcSEcCtD
Propranolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00177	CcSEcCtD
Propranolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00177	CcSEcCtD
Propranolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00177	CcSEcCtD
Propranolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00177	CcSEcCtD
Propranolol—Metoprolol—ADRB2—chronic obstructive pulmonary disease	0.00011	0.033	CrCbGaD
Propranolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00174	CcSEcCtD
Propranolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000109	0.00173	CcSEcCtD
Propranolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.00173	CcSEcCtD
Propranolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00169	CcSEcCtD
Propranolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00168	CcSEcCtD
Propranolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00165	CcSEcCtD
Propranolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00165	CcSEcCtD
Propranolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00163	CcSEcCtD
Propranolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	0.000102	0.0305	CrCbGaD
Propranolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00161	CcSEcCtD
Propranolol—Duloxetine—SLC6A4—chronic obstructive pulmonary disease	0.000102	0.0304	CrCbGaD
Propranolol—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.0016	CcSEcCtD
Propranolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.00159	CcSEcCtD
Propranolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0001	0.00159	CcSEcCtD
Propranolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.84e-05	0.00156	CcSEcCtD
Propranolol—Neutropenia—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.00156	CcSEcCtD
Propranolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.82e-05	0.00156	CcSEcCtD
Propranolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.00153	CcSEcCtD
Propranolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.66e-05	0.00153	CcSEcCtD
Propranolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.66e-05	0.00153	CcSEcCtD
Propranolol—Rash—Arformoterol—chronic obstructive pulmonary disease	9.58e-05	0.00152	CcSEcCtD
Propranolol—Rash—Formoterol—chronic obstructive pulmonary disease	9.58e-05	0.00152	CcSEcCtD
Propranolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.57e-05	0.00152	CcSEcCtD
Propranolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.57e-05	0.00152	CcSEcCtD
Propranolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.0015	CcSEcCtD
Propranolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.46e-05	0.0015	CcSEcCtD
Propranolol—Rash—Montelukast—chronic obstructive pulmonary disease	9.38e-05	0.00149	CcSEcCtD
Propranolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.37e-05	0.00149	CcSEcCtD
Propranolol—Depression—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.00148	CcSEcCtD
Propranolol—Duloxetine—CYP1A2—chronic obstructive pulmonary disease	9.25e-05	0.0277	CrCbGaD
Propranolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.12e-05	0.00145	CcSEcCtD
Propranolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.00144	CcSEcCtD
Propranolol—Rash—Salbutamol—chronic obstructive pulmonary disease	9.05e-05	0.00143	CcSEcCtD
Propranolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.04e-05	0.00143	CcSEcCtD
Propranolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.02e-05	0.00143	CcSEcCtD
Propranolol—Nausea—Formoterol—chronic obstructive pulmonary disease	9.02e-05	0.00143	CcSEcCtD
Propranolol—Nausea—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.0014	CcSEcCtD
Propranolol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.00138	CcSEcCtD
Propranolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.00136	CcSEcCtD
Propranolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.52e-05	0.00135	CcSEcCtD
Propranolol—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.00133	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.0013	CcSEcCtD
Propranolol—Duloxetine—HTR2A—chronic obstructive pulmonary disease	7.81e-05	0.0233	CrCbGaD
Propranolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.44e-05	0.00118	CcSEcCtD
Propranolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.44e-05	0.00118	CcSEcCtD
Propranolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.39e-05	0.00117	CcSEcCtD
Propranolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.00117	CcSEcCtD
Propranolol—Erythema—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.00116	CcSEcCtD
Propranolol—Carvedilol—ADRB2—chronic obstructive pulmonary disease	7.32e-05	0.0219	CrCbGaD
Propranolol—Pain—Prednisolone—chronic obstructive pulmonary disease	7.04e-05	0.00112	CcSEcCtD
Propranolol—Agitation—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.00107	CcSEcCtD
Propranolol—Propafenone—CYP1A2—chronic obstructive pulmonary disease	6.72e-05	0.0201	CrCbGaD
Propranolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.00104	CcSEcCtD
Propranolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.00104	CcSEcCtD
Propranolol—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.00101	CcSEcCtD
Propranolol—Carvedilol—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.0188	CrCbGaD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000982	CcSEcCtD
Propranolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.06e-05	0.000961	CcSEcCtD
Propranolol—Carvedilol—CYP1A2—chronic obstructive pulmonary disease	6.05e-05	0.0181	CrCbGaD
Propranolol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000948	CcSEcCtD
Propranolol—Infection—Prednisone—chronic obstructive pulmonary disease	5.94e-05	0.000942	CcSEcCtD
Propranolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000929	CcSEcCtD
Propranolol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000921	CcSEcCtD
Propranolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.000862	CcSEcCtD
Propranolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000857	CcSEcCtD
Propranolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000851	CcSEcCtD
Propranolol—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	5.32e-05	0.0159	CrCbGaD
Propranolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000834	CcSEcCtD
Propranolol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000824	CcSEcCtD
Propranolol—Rash—Prednisolone—chronic obstructive pulmonary disease	5.19e-05	0.000822	CcSEcCtD
Propranolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.18e-05	0.000822	CcSEcCtD
Propranolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000817	CcSEcCtD
Propranolol—Constipation—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.00081	CcSEcCtD
Propranolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000775	CcSEcCtD
Propranolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.89e-05	0.000775	CcSEcCtD
Propranolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000753	CcSEcCtD
Propranolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000749	CcSEcCtD
Propranolol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000749	CcSEcCtD
Propranolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000698	CcSEcCtD
Propranolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.29e-05	0.00068	CcSEcCtD
Propranolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.09e-05	0.000648	CcSEcCtD
Propranolol—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	4.09e-05	0.0122	CrCbGaD
Propranolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000627	CcSEcCtD
Propranolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000603	CcSEcCtD
Propranolol—Rash—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000598	CcSEcCtD
Propranolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000597	CcSEcCtD
Propranolol—Nausea—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000563	CcSEcCtD
Propranolol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000396	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.2e-05	0.000395	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.2e-05	0.000393	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.17e-05	0.000386	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.17e-05	0.000384	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000381	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000379	CbGpPWpGaD
Propranolol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000376	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.14e-05	0.000373	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.000372	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000371	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.000363	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.1e-05	0.000362	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000344	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.04e-05	0.000342	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000338	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.03e-05	0.000338	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.03e-05	0.000337	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.000335	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000331	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1e-05	0.00033	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1e-05	0.000329	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1e-05	0.000328	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.86e-06	0.000324	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.86e-06	0.000324	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.85e-06	0.000324	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.78e-06	0.000321	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	9.76e-06	0.000321	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.76e-06	0.000321	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	9.66e-06	0.000317	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.65e-06	0.000317	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.65e-06	0.000317	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.64e-06	0.000317	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.46e-06	0.000311	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.43e-06	0.00031	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.00031	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.38e-06	0.000308	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.36e-06	0.000307	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.33e-06	0.000306	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.31e-06	0.000306	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.3e-06	0.000305	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.2e-06	0.000302	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.15e-06	0.000301	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.08e-06	0.000298	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.05e-06	0.000297	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.01e-06	0.000296	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.95e-06	0.000294	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	8.82e-06	0.00029	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.82e-06	0.00029	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.81e-06	0.000289	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.62e-06	0.000283	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.62e-06	0.000283	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.56e-06	0.000281	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.55e-06	0.000281	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.52e-06	0.00028	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.47e-06	0.000278	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.42e-06	0.000276	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.19e-06	0.000269	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.15e-06	0.000268	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.13e-06	0.000267	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.11e-06	0.000266	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.11e-06	0.000266	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.01e-06	0.000263	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.01e-06	0.000263	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.83e-06	0.000257	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	7.79e-06	0.000256	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.78e-06	0.000256	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.77e-06	0.000255	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.57e-06	0.000249	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.45e-06	0.000244	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.41e-06	0.000243	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.3e-06	0.00024	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.25e-06	0.000238	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.21e-06	0.000237	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.07e-06	0.000232	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.05e-06	0.000232	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.99e-06	0.00023	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	6.99e-06	0.000229	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.95e-06	0.000228	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.94e-06	0.000228	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.9e-06	0.000226	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.78e-06	0.000223	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.77e-06	0.000222	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.7e-06	0.00022	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.68e-06	0.000219	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.68e-06	0.000219	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.67e-06	0.000219	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.6e-06	0.000217	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.56e-06	0.000215	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.41e-06	0.000211	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	6.38e-06	0.000209	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.35e-06	0.000209	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.31e-06	0.000207	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.23e-06	0.000204	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.23e-06	0.000204	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.22e-06	0.000204	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.19e-06	0.000203	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.18e-06	0.000203	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.15e-06	0.000202	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.13e-06	0.000201	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.07e-06	0.000199	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.02e-06	0.000198	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.01e-06	0.000197	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.94e-06	0.000195	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.92e-06	0.000194	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.9e-06	0.000194	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.89e-06	0.000194	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.87e-06	0.000193	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.77e-06	0.00019	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.67e-06	0.000186	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.65e-06	0.000185	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.59e-06	0.000184	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.57e-06	0.000183	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.55e-06	0.000182	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.53e-06	0.000181	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.46e-06	0.000179	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.45e-06	0.000179	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.41e-06	0.000178	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	5.4e-06	0.000177	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.33e-06	0.000175	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.33e-06	0.000175	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.29e-06	0.000174	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.27e-06	0.000173	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.06e-06	0.000166	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.04e-06	0.000165	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.03e-06	0.000165	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.03e-06	0.000165	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.02e-06	0.000165	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.97e-06	0.000163	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.95e-06	0.000162	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	4.93e-06	0.000162	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.92e-06	0.000161	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.9e-06	0.000161	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.84e-06	0.000159	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.84e-06	0.000159	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.83e-06	0.000159	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.81e-06	0.000158	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.81e-06	0.000158	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.79e-06	0.000157	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.73e-06	0.000155	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.67e-06	0.000153	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.64e-06	0.000152	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.63e-06	0.000152	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.63e-06	0.000152	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.56e-06	0.00015	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.55e-06	0.000149	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.54e-06	0.000149	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.53e-06	0.000149	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.5e-06	0.000148	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.5e-06	0.000148	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.43e-06	0.000146	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.43e-06	0.000145	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.4e-06	0.000144	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.3e-06	0.000141	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.27e-06	0.00014	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.26e-06	0.00014	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.25e-06	0.00014	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.23e-06	0.000139	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.21e-06	0.000138	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.18e-06	0.000137	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.09e-06	0.000134	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.01e-06	0.000132	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.01e-06	0.000132	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.92e-06	0.000129	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.84e-06	0.000126	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-06	0.000126	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.83e-06	0.000126	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.79e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.75e-06	0.000123	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.75e-06	0.000123	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.74e-06	0.000123	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.7e-06	0.000121	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.7e-06	0.000121	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.68e-06	0.000121	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.65e-06	0.00012	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.62e-06	0.000119	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.57e-06	0.000117	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.54e-06	0.000116	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.53e-06	0.000116	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.48e-06	0.000114	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.48e-06	0.000114	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.45e-06	0.000113	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.44e-06	0.000113	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.4e-06	0.000112	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.39e-06	0.000111	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.37e-06	0.000111	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.37e-06	0.000111	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.3e-06	0.000108	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.29e-06	0.000108	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.29e-06	0.000108	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.25e-06	0.000107	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.22e-06	0.000106	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.22e-06	0.000106	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.2e-06	0.000105	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.09e-06	0.000101	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.05e-06	0.0001	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.03e-06	9.96e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.99e-06	9.81e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.96e-06	9.73e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.95e-06	9.69e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.92e-06	9.6e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.91e-06	9.56e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	2.9e-06	9.53e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.86e-06	9.38e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.84e-06	9.33e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.83e-06	9.28e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.8e-06	9.18e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.78e-06	9.12e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.77e-06	9.11e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.74e-06	9e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.74e-06	9e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.73e-06	8.97e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.72e-06	8.92e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-06	8.9e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.7e-06	8.87e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.64e-06	8.68e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.62e-06	8.61e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.58e-06	8.49e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.57e-06	8.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.43e-06	7.97e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.37e-06	7.79e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.32e-06	7.62e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.3e-06	7.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.28e-06	7.48e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.25e-06	7.38e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.24e-06	7.36e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.23e-06	7.31e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.19e-06	7.19e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.18e-06	7.17e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.18e-06	7.15e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.15e-06	7.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.14e-06	7.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.13e-06	6.99e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.11e-06	6.92e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-06	6.88e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.09e-06	6.87e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.09e-06	6.86e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.06e-06	6.77e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.98e-06	6.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.97e-06	6.48e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.83e-06	6.02e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.79e-06	5.89e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.75e-06	5.76e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.75e-06	5.74e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.68e-06	5.51e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.67e-06	5.49e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.64e-06	5.39e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.61e-06	5.27e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.35e-06	4.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.29e-06	4.24e-05	CbGpPWpGaD
